These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26199172)

  • 1. Evaluation of Intravesical Prostatic Protrusion as a Predictor of Dutasteride-Resistant Lower Urinary Tract Symptoms/Benign Prostatic Enlargement With a High Likelihood of Surgical Intervention.
    Hirayama K; Masui K; Hamada A; Shichiri Y; Masuzawa N; Hamada S
    Urology; 2015 Sep; 86(3):565-9. PubMed ID: 26199172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical Prostatic Protrusion as a Predicting Factor for the Adverse Clinical Outcome in Patients With Symptomatic Benign Prostatic Enlargement Treated With Dutasteride.
    Yoshida T; Kinoshita H; Yoshida K; Mishima T; Taniguchi H; Yanishi M; Komai Y; Yasuda K; Sugi M; Matsuda T
    Urology; 2016 May; 91():154-7. PubMed ID: 26826590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of resistive index of the prostate and bladder sonomorphologic parameters as replacements for urodynamics to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Garg G; Sankhwar SN; Goel A; Pandey S; Sharma D; Parihar A
    Low Urin Tract Symptoms; 2019 May; 11(3):163-168. PubMed ID: 30793849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which is a better indicator of bladder outlet obstruction in patients with benign prostatic enlargement--intravesical protrusion of prostate or bladder wall thickness?
    Aganovic D; Hasanbegovic M; Prcic A; Kulovac B; Hadziosmanovic O
    Med Arch; 2012; 66(5):324-8. PubMed ID: 23097971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The relationship between intravesical prostatic protrusion and pressure flow study findings in patients with benign prostate obstruction/lower urinary tract symptoms].
    Park SC; Lee JW; Rim JS
    Actas Urol Esp; 2012 Mar; 36(3):165-70. PubMed ID: 22018947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical prostatic protrusion can predict therapeutic response to silodosin in male patients with lower urinary tract symptoms.
    Matsukawa Y; Ishida S; Majima T; Funahashi Y; Sassa N; Kato M; Yoshino Y; Gotoh M
    Int J Urol; 2017 Jun; 24(6):454-459. PubMed ID: 28370376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased urinary nerve growth factor reflects prostatic volume reduction and relief of outlet obstruction in patients with benign prostatic enlargement treated with dutasteride.
    Wada N; Matsumoto S; Kita M; Hashizume K; Kakizaki H
    Int J Urol; 2014 Dec; 21(12):1258-62. PubMed ID: 25039474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dutasteride add-on therapy reduces detrusor mass in patients with benign prostatic enlargement not satisfied with alpha-adrenergic antagonist monotherapy: A single center prospective study.
    De Nunzio C; Brassetti A; Proietti F; Gacci M; Serni S; Esperto F; Tubaro A
    Neurourol Urodyn; 2017 Nov; 36(8):2096-2100. PubMed ID: 28257560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of intravesical prostatic protrusion in patients with benign prostatic enlargement.
    Keqin Z; Zhishun X; Jing Z; Haixin W; Dongqing Z; Benkang S
    Urology; 2007 Dec; 70(6):1096-9. PubMed ID: 18158025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical impact of the intravesical prostatic protrusion: a review by the LUTS committee of the French Urological Association].
    Lebdai S; Ammi M; Bigot P; Cornu JN; Mathieu R; Descazeaud A; Azzouzi AR;
    Prog Urol; 2014 Apr; 24(5):313-8. PubMed ID: 24674338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What are the predicting factors for the therapeutic effects of dutasteride in male patients with lower urinary tract symptoms? Investigation using a urodynamic study.
    Matsukawa Y; Kato M; Funahashi Y; Majima T; Yamamoto T; Gotoh M
    Neurourol Urodyn; 2017 Sep; 36(7):1809-1815. PubMed ID: 28102554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of intravesical prostatic protrusion and resistive index is useful to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Suzuki T; Otsuka A; Ozono S
    Int J Urol; 2016 Nov; 23(11):929-933. PubMed ID: 27545297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound image features of intravesical prostatic protrusion indicated failure of medication therapy of finasteride and doxazosin in patients with benign prostatic hyperplasia (LUTS/BPH).
    Liu Q; Zhu Y; Liu J; Qi J; Kang J
    Int Urol Nephrol; 2017 Mar; 49(3):399-404. PubMed ID: 27987130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intravesical prostatic protrusion, prostate volume and serum prostatic-specific antigen in the evaluation of bladder outlet obstruction.
    Lim KB; Ho H; Foo KT; Wong MY; Fook-Chong S
    Int J Urol; 2006 Dec; 13(12):1509-13. PubMed ID: 17118026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravesical prostatic protrusion can be a predicting factor for the treatment outcome in patients with lower urinary tract symptoms due to benign prostatic obstruction treated with tamsulosin.
    Cumpanas AA; Botoca M; Minciu R; Bucuras V
    Urology; 2013 Apr; 81(4):859-63. PubMed ID: 23375910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Withdrawing α1-Blocker from Combination Therapy with α1-Blocker and 5α-Reductase Inhibitor in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Prospective and Comparative Trial Using Urodynamics.
    Matsukawa Y; Takai S; Funahashi Y; Majima T; Kato M; Yamamoto T; Gotoh M
    J Urol; 2017 Oct; 198(4):905-912. PubMed ID: 28499730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia].
    Bantis A; Zissimopoulos A; Kalaytzis C; Giannakopoulos S; Sountoulides P; Agelonidou E; Voudalikakis C; Touloupidis S
    Hell J Nucl Med; 2007; 10(2):138-43. PubMed ID: 17684595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between prostate volume and intravesical prostatic protrusion in detecting bladder outlet obstruction due to benign prostatic hyperplasia.
    Hossain AK; Alam AK; Habib AK; Rashid MM; Rahman H; Islam AK; Jahan MU
    Bangladesh Med Res Counc Bull; 2012 Apr; 38(1):14-7. PubMed ID: 22545345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravescical prostatic protrusion is a predictor of alpha blockers response: results from an observational study.
    Topazio L; Perugia C; De Nunzio C; Gaziev G; Iacovelli V; Bianchi D; Vespasiani G; Finazzi Agrò E
    BMC Urol; 2018 Feb; 18(1):6. PubMed ID: 29394926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transabdominal ultrasound measurement of intravesical prostatic protrusion helps diagnosis of benign prostatic obstruction].
    Yu HF; He YH; Yu KY; Wang Q; Huang PT; Yang Y; Wu DZ; Chen YH
    Zhonghua Nan Ke Xue; 2008 Jul; 14(7):628-30. PubMed ID: 18686385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.